Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Ranolazine for Angina in Hypertrophic Cardiomyopathy
View through CrossRef
Ranolazine is an antianginal and works by inhibiting late-sodium current (INaL). However, its use is limited mostly to patients with coronary artery disease. However, literature has shown its potential benefit in relieving angina in hypertrophic cardiomyopathy. Hereby, we discuss two cases where ranolazine led to improvement in angina refractory to beta-blockers. In conclusion, ranolazine can be considered as a potential antianginal drug in patients with hypertrophic cardiomyopathy refractory to beta-blockers.
Title: Ranolazine for Angina in Hypertrophic Cardiomyopathy
Description:
Ranolazine is an antianginal and works by inhibiting late-sodium current (INaL).
However, its use is limited mostly to patients with coronary artery disease.
However, literature has shown its potential benefit in relieving angina in hypertrophic cardiomyopathy.
Hereby, we discuss two cases where ranolazine led to improvement in angina refractory to beta-blockers.
In conclusion, ranolazine can be considered as a potential antianginal drug in patients with hypertrophic cardiomyopathy refractory to beta-blockers.
Related Results
Ranolazine-Tacrolimus Interaction
Ranolazine-Tacrolimus Interaction
Objective:
To report the case of a kidney allograft recipient on a stable regimen of tacrolimus who exhibited increased tacrolimus concentrations within 24 hour...
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Background: Coronary flow with a diastolic predominance increases two to five times in hyperemia, mediated by vasodilation (coronary flow reserve, CFR) and, in hypertrophy, relativ...
A Rare Neurological Complication of Ranolazine
A Rare Neurological Complication of Ranolazine
Myoclonus is not a known side effect of ranolazine. We report a case of myoclonus in a 72-year-old female who underwent cardiac catheterization for angina and was started on ranola...
Current management of hypertrophic cardiomyopathy
Current management of hypertrophic cardiomyopathy
ABSTRACT
Hypertrophic cardiomyopathy is a common yet under-recognized genetic structural heart condition characterized by left ventricular hypertrophy. Patients m...
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
Background
Takotsubo cardiomyopathy, also known as stress cardiomyopathy and broken heart syndrome, is a transient, non-ischemic cardiomyopathy marked by revers...
COMPARISON OF EFFICACY AND SAFETY OF RANOLAZINE AND IVABRADINE IN CHRONIC ISCHEMIC HEART DISEASE PATIENTS
COMPARISON OF EFFICACY AND SAFETY OF RANOLAZINE AND IVABRADINE IN CHRONIC ISCHEMIC HEART DISEASE PATIENTS
Background: Ischemic heart disease (IHD) frequently produces persistent angina that may significantly impair quality of life despite standard treatment. There is need for effectiv...
Differentiation of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
Differentiation of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
ABSTRACT. Eriksson P, Backman C, Eriksson A, Eriksson S, Karp K, Olofsson B‐O (Departments of Internal Medicine, Geriatric Medicine, and Clinical Physiology, University Hospital, ...
Extended Myectomy for Apical Hypertrophic Cardiomyopathy: A Case Report
Extended Myectomy for Apical Hypertrophic Cardiomyopathy: A Case Report
Abstract
BackgroundApical hypertrophic cardiomyopathy is a variant of hypertrophic cardiomyopathy that predominantly affects the left ventricle apex and rarely involves the...